Concepedia

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine

Wolfgang Kruis, Simon Bar–Meir, János Fehér, O Mickisch, Horst Mlitz, M. Faszczyk, Yehuda Chowers, Gabriella Lengyele, Ágota Kovács, Manfred Stolte,

Clinical Gastroenterology and Hepatology · 2003 · 114 citations · 16 references

DOI

Concepts

References

16

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

Kenneth W. Schroeder, William J. Tremaine, Duane M. Ilstrup · New England Journal of Medicine · 1987 · 3K citations

, , +14

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Daniel Rachmilewitz · BMJ · 1989 · 1K citations · Full text

, , +15

Microscopic activity in ulcerative colitis: what does it mean?

S A Riley, V Mani, Michael J. Goodman et al. · Gut · 1991 · 576 citations · Full text

, , +16

Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.

S. Hanauer, JACOB SCHWARTZ, Malcolm Robinson et al. · PubMed · 1993 · 269 citations

, , +15

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

S A Riley, V Mani, Michael J. Goodman et al. · Gut · 1988 · 194 citations · Full text

, , +13